Albany, NY -- (SBWIRE) -- 01/10/2018 -- Duodenal ulcer, also called as peptic ulcer is a defect in the lining of the small intestine, an area called duodenum. The lining which protects the small intestine is resistant against the acid which is produced in our stomach. If the protecting line fails to protect the intestine or does not work properly against the acid it results in an ulcer. A causative microorganism for duodenal ulcer is helicobacter pylori, a gram-negative, microaerophilic bacteria. Common symptoms for duodenal ulcer includes abdominal pain, pain or discomfort in the upper abdomen, feeling of plumpness, blood in vomiting and chest pain. Risk factor of duodenal ulcer includes drinking too much alcohol, regular use of non-steroidal anti-inflammatory drugs and smoking cigarettes or chewing tobacco. Duodenal ulcer can be diagnosed by esophagogastroduodenoscopy (EGD), X ray of Upper GI and endoscopy. Treatment option utilized for the cure of duodenal ulcer includes antibiotic medication (amoxicillin, tetracycline) and proton pump inhibitor medication (lansoprazoleor esomeprazole).

Browse Premium Industry Research Report with Analysis: https://www.transparencymarketresearch.com/duodenal-ulcer-treatment.html

Cigarette smokers and people with the habit of drinking alcohol is increasing rapidly across the world. Moreover steady diet of fast food eaters is also increasing significantly around the world. These above mentioned (cigarette smokers, fast food eaters, alcohol drinkers) people are at high risk of getting duodenal ulcer and thus accentuates the global duodenal ulcer treatment market. However, lack of awareness about duodenal ulcer might restrict the demand of the global market.

Request for Sample Copy of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2319

Geographically, North America and Europe dominate the global market for duodenal ulcer treatment due to a strong demand for molecular-based diagnostics and high prevalence rate of duodenal ulcer. Asia-Pacific and RoW hold the third and fourth position in the global market due to lack of awareness among people about duodenal ulcer and less prevalence rate of duodenal ulcer in this regions.

Some of the market players contributing the global market share of duodenal ulcer treatment includes GlaxoSmithKline, Pfizer, Abbott, Merck and Co., Cipla Laboratories, Novartis AG, Bristol Meyer Squibb and Reddys Lab.

Pre Book this Report: https://www.transparencymarketresearch.com